JPRN-UMIN000002899招募中未知
A clinical study of the living-unrelated renal transplantation with restored kidneys (interventional trial) - A clinical study of the living renal transplantation with restored kidneys between third parties
Tokushukai Medical Group0 个研究点目标入组 20 人开始时间: 2009年12月15日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 发起方
- 入组人数
- 20
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •For Recipient: 1) Patients having infectious disease, hemorrhagic ulcer, or malignant cancer 2) Patients having serious vascular lesions (eg. Arteriosclerosis, thromboembolic disease) and currently on treatment 3) Patients not approved by the Institutional Ethics Committee For Donor: 1) Patients positive for serious infectious disease (eg. HIV, HBV, or HCV) 2) Patients diagnosed as having malignant lymphoma or sarcoma 3) Patients on chemotherapy or radiation therapy for renal cancer prior to the nephrectomy 4) Patients not approved by the Institutional Ethics Committee (*) Other exclusion criteria defined in the protocol for both recipient and donor may apply.
研究者
相似试验
招募中
不适用
A clinical study of living-related renal transplantation with restored kidneys (interventional trial)iving renal transplantations between family members with restored donor kidneys in order to acquire necessary clinical data for potential enrichment of the renal donor pool in Japan as well as to develop useful medical care for patients who are on dialysis for many years due to the renal failure.JPRN-UMIN000003257Tokushukai Medical Group5
尚未招募
不适用
A study of kidney Problems with covid 19 in admitted patients at a teritiary care hospital.CTRI/2020/12/029581nil
招募中
不适用
A clinical study to evaluate the effect of renal impairment of the pharmacokinetics of oral administration of Factive Tab. 320mgDiseases of the genitourinary systemKCT0006146Chonnam National University Hospital28
进行中（未招募）
1 期
Evaluation of the impact of renal function on the pharmacokinetics of hydroxyurea (Siklos®) in patients with sickle cell disease with normal renal function, with hyperfiltration, or with renal failure. DARH studySiklos is indicated for the prevention of recurrent painful vaso-occlusive crises including acute chest syndrome in adults, adolescents and children older than 2 years suffering from symptomatic sickle cell syndrome.MedDRA version: 17.1Level: LLTClassification code 10040643Term: Sickle cell crisisSystem Organ Class: 100000004851EUCTR2014-005033-31-FRAddmedica S.A.S
已完成
3 期
Renal complications of Amikacin in patients with neonatal sepsisIRCT20201212049686N1Tehran University of Medical Sciences90